esmolol has been researched along with Atrial Fibrillation in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (16.67) | 18.7374 |
1990's | 5 (16.67) | 18.2507 |
2000's | 10 (33.33) | 29.6817 |
2010's | 10 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Er, F; Gassanov, N | 1 |
Han, J; Liu, RC; Sun, DF; Sun, SH; Wang, LJ; Wu, Y; Yang, L | 1 |
Carre, JL; Lamoureux, C; Le Saos, F; Leven, C; Sakka, M; Vermeersch, V | 1 |
Beltramini, A; Lambert, Y; Milojevic, K; Muret, A; Nagash, M; Richard, O | 1 |
Guo, F; Li, Q; Lu, B; Zheng, YY | 1 |
Corino, VD; Holmqvist, F; Mainardi, LT; Platonov, PG | 1 |
Corino, VD; Mainardi, LT; Platonov, PG; Sandberg, F; Sörnmo, L | 1 |
Arrigo, M; Bettex, D; Rudiger, A | 1 |
Bikias, A; Delithanasis, I; Fragakis, N; Katsaris, G; Konstantinidou, M; Kozirakis, M; Liakopoulos, N | 1 |
Guo, JH; Jackman, WM; Jiang, H; Lazzara, R; Lin, J; Lu, Z; Niu, G; Po, SS; Scherlag, BJ; Yu, L | 1 |
Shen, SL; Zhao, YC | 1 |
Calame, J; Calame, S; Gallo, A; Habel, N; Lustgarten, DL; Müller, JG; Noori, A; Sobel, BE; Spector, PS; Thompson, N; Znojkiewicz, P | 1 |
Klemm, H; Meinertz, T; Sturm, N; Ventura, R; Weiss, C; Willems, S | 1 |
Hilleman, DE; Mooss, AN; Packard, KA; Reyes, AP | 1 |
Bauer, A; Donahue, JK; Heldman, AW; McDonald, AD; Miller, JM; Nasir, K; Peller, L; Rade, JJ | 1 |
Ahmad, S; Ahmed, S; Hassan, S; Kakish, E; Kamalakannan, D; Khoury, R; Kronick, SL; Maria, V; Morady, F; Oral, H; Pires, LA; Slim, AM | 1 |
Alt, E; Hulse, J; Kartzinel, R; Klein, G; Laddu, AR; Lee, R; Saunders, R; Steck, J; Wirtzfeld, A | 1 |
Lennon, PF; Risk, SC | 1 |
Appunn, DO; Shettigar, UR; Toole, JG | 1 |
Herbert, ME; Rutz, F; Votey, SR | 1 |
Bolar-Softich, KL; Elam, K | 1 |
Abreu, JE; Clyne, CA; Jekel, JF; Khachane, VB; Reilly, J; Salzano, RP | 1 |
Hilleman, DE; Mohiuddin, SM; Mooss, AN; Reyes, AP; Scott, W; Seyedroudbari, A; Sugimoto, JT; Wurdeman, RL | 1 |
Balcetyte-Harris, N; Homel, P; Menchavez, E; Steinberg, JS; Tamis, JE | 1 |
Hou, Y; Jackman, WM; Lazzara, R; Schauerte, P; Scherlag, BJ; Scherlag, M; Sun, YX; Yamanashi, WS | 1 |
Bares, AC; Hsu, W; Knight, BP; Morady, F; Oral, H; Pelosi, F; Sticherling, C; Strickberger, SA; Tada, H | 1 |
Das, G; Michelson, EL; Platia, EV; Porterfield, JK | 1 |
Bateman, TM; Conklin, CM; Czer, LS; Gray, RJ; Matloff, JM | 1 |
Burge, J; Katz, RJ; Keefe, D; Laddu, AR; Somberg, JC; Steinberg, JS | 1 |
MacVaugh, H; Michelson, EL; Sawin, HS; Schwartz, M | 1 |
3 review(s) available for esmolol and Atrial Fibrillation
Article | Year |
---|---|
[The Role of Ultrarapid Acting Betablocker Esmolol and Landiolol in Critically Ill Patients].
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Critical Illness; Humans; Morpholines; Propanolamines; Urea | 2019 |
[Treatment of atrial fibrillation in intensive care units and emergency departments].
Topics: Adrenergic beta-Antagonists; Anisoles; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Combined Modality Therapy; Critical Illness; Electric Countershock; Electrocardiography; Emergency Service, Hospital; Hemodynamics; Humans; Intensive Care Units; Propanolamines; Pyrrolidines | 2015 |
Dilemmas in the acute pharmacologic treatment of uncontrolled atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Digoxin; Diltiazem; Emergency Medical Services; Humans; Propanolamines | 1997 |
14 trial(s) available for esmolol and Atrial Fibrillation
Article | Year |
---|---|
Effects of vasodilator and esmolol-induced hemodynamic stability on early post-operative cognitive dysfunction in elderly patients: a randomized trial.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Catheter Ablation; Cognitive Dysfunction; Female; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Mental Status and Dementia Tests; Nicardipine; Nitroglycerin; Postoperative Complications; Propanolamines; Vasodilator Agents | 2016 |
Beta-blockade and A1-adenosine receptor agonist effects on atrial fibrillatory rate and atrioventricular conduction in patients with atrial fibrillation.
Topics: Adenosine; Administration, Intravenous; Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Furans; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Purinergic P1 Receptor Agonists; Time Factors; Treatment Outcome | 2014 |
Noninvasive Assessment of Atrioventricular Nodal Function: Effect of Rate-Control Drugs during Atrial Fibrillation.
Topics: Adenosine; Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Female; Furans; Humans; Male; Middle Aged; Propanolamines; Purinergic P1 Receptor Agonists | 2015 |
Acute beta-adrenoceptor blockade improves efficacy of ibutilide in conversion of atrial fibrillation with a rapid ventricular rate.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Synergism; Female; Humans; Male; Middle Aged; Propanolamines; Sulfonamides; Treatment Outcome; Ventricular Fibrillation | 2009 |
[A comparative study on the efficacy and safety of intravenous esmolol, amiodarone and diltiazem for controlling rapid ventricular rate of patients with atrial fibrillation during anesthesia period].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anesthesia; Atrial Fibrillation; Child; Diltiazem; Female; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Treatment Outcome; Young Adult | 2010 |
Conversion of atrial fibrillation to sinus rhythm during treatment with intravenous esmolol or diltiazem: a prospective, randomized comparison.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atrial Fibrillation; Calcium Channel Blockers; Diltiazem; Emergency Service, Hospital; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Propanolamines; Prospective Studies; Treatment Outcome | 2007 |
Antiarrhythmic activity of esmolol (ASL-8052)--a novel ultra-short acting beta-adrenoreceptor blocking agent.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Heart Rate; Humans; Infusions, Parenteral; Male; Middle Aged; Propanolamines | 1984 |
Combined use of esmolol and digoxin in the acute treatment of atrial fibrillation or flutter.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Atrial Flutter; Digoxin; Drug Therapy, Combination; Heart Rate; Humans; Propanolamines; Time Factors | 1993 |
Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atrial Fibrillation; Atrial Flutter; Coronary Artery Bypass; Cost-Benefit Analysis; Diltiazem; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Postoperative Complications; Probability; Prognosis; Propanolamines; Reference Values; Survival Rate; Treatment Outcome | 2000 |
Randomized study of early intravenous esmolol versus oral beta-blockers in preventing post-CABG atrial fibrillation in high risk patients identified by signal-averaged ECG: results of a pilot study.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Bradycardia; Coronary Artery Bypass; Drug Administration Schedule; Electrocardiography; Female; Humans; Hypotension; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Postoperative Complications; Propanolamines | 2002 |
Effects of diltiazem and esmolol on cycle length and spontaneous conversion of atrial fibrillation.
Topics: Adult; Atrial Fibrillation; Blood Pressure; Calcium Channel Blockers; Diltiazem; Female; Humans; Male; Middle Aged; Propanolamines; Time Factors | 2002 |
Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Clinical Trials as Topic; Digoxin; Female; Heart Rate; Humans; Male; Middle Aged; Multicenter Studies as Topic; Propanolamines; Random Allocation; Verapamil | 1989 |
Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Clinical Trials as Topic; Female; Fluorobenzenes; Half-Life; Humans; Hypotension; Male; Middle Aged; Myocardial Contraction; Propanolamines; Time Factors | 1986 |
Esmolol: safety and efficacy in postoperative cardiothoracic patients with supraventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Clinical Trials as Topic; Coronary Artery Bypass; Female; Heart Rate; Heart Valve Prosthesis; Humans; Male; Postoperative Complications; Propanolamines; Time Factors | 1988 |
13 other study(ies) available for esmolol and Atrial Fibrillation
Article | Year |
---|---|
Methanol detection after esmolol infusion in intensive care unit: a case report.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Humans; Infusion Pumps; Intensive Care Units; Intestinal Neoplasms; Liver Neoplasms; Male; Methanol; Middle Aged; Neuroendocrine Tumors; Propanolamines; Renal Dialysis | 2017 |
Esmolol Compared with Amiodarone in the Treatment of Recent-Onset Atrial Fibrillation (RAF): An Emergency Medicine External Validity Study.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Emergency Medicine; Emergency Service, Hospital; Female; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Retrospective Studies; Surveys and Questionnaires; Time Factors | 2019 |
Comment on the article: "Microvascular effects of intravenous esmolol in patients with normal cardiac function undergoing postoperative atrial fibrillation: a prospective pilot study in cardiothoracic surgery".
Topics: Atrial Fibrillation; Humans; Pilot Projects; Propanolamines; Prospective Studies | 2019 |
Autonomic mechanism for initiation of rapid firing from atria and pulmonary veins: evidence by ablation of ganglionated plexi.
Topics: Adrenergic beta-Antagonists; Animals; Atrial Fibrillation; Atropine; Autonomic Denervation; Cardiac Pacing, Artificial; Catheter Ablation; Disease Models, Animal; Dogs; Electrophysiologic Techniques, Cardiac; Ganglia, Autonomic; Heart Atria; Injections, Intravenous; Muscarinic Antagonists; Propanolamines; Pulmonary Veins | 2009 |
The impact of pharmacologic sympathetic and parasympathetic blockade on atrial electrogram characteristics in patients with atrial fibrillation.
Topics: Adrenergic beta-1 Receptor Antagonists; Atrial Fibrillation; Atropine; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Nerve Block; Parasympatholytics; Propanolamines; Sympathetic Nervous System; Sympatholytics; Treatment Outcome | 2011 |
Atrial premature beats in patients with focal atrial fibrillation: incidence at baseline and impact of provocative maneuvers.
Topics: Adenosine; Adrenergic Fibers; Atrial Fibrillation; Atrial Premature Complexes; Electrocardiography, Ambulatory; Electrophysiologic Techniques, Cardiac; Female; Humans; Male; Metaproterenol; Middle Aged; Propanolamines; Sodium Chloride; Vagus Nerve | 2002 |
Esmolol versus diltiazem in atrial fibrillation following coronary artery bypass graft surgery.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Calcium Channel Blockers; Coronary Artery Bypass; Diltiazem; Female; Humans; Male; Medical Records; Postoperative Complications; Propanolamines; Retrospective Studies; Treatment Outcome | 2003 |
Inhibitory G protein overexpression provides physiologically relevant heart rate control in persistent atrial fibrillation.
Topics: Acute Disease; Adenoviridae; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Cardiac Pacing, Artificial; Digoxin; Diltiazem; Gene Expression Regulation; Genetic Therapy; Genetic Vectors; GTP-Binding Protein alpha Subunit, Gi2; GTP-Binding Protein alpha Subunits, Gi-Go; Heart Failure; Heart Rate; Propanolamines; Proto-Oncogene Proteins; Recombinant Fusion Proteins; Stroke Volume; Sus scrofa; Ultrasonography | 2004 |
Successful treatment of low cardiac output syndrome with beta-adrenergic blockade because of improved effectiveness of an intra-aortic balloon pump.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Cardiac Output, Low; Cardiac Pacing, Artificial; Coronary Artery Bypass; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Propanolamines; Syndrome; Ventricular Dysfunction | 1995 |
New treatment of atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Calcium Channel Blockers; Digoxin; Diltiazem; Drug Therapy, Combination; Emergency Medicine; Heart Failure; Humans; Propanolamines; Verapamil | 1996 |
Comparison of frequencies of atrial fibrillation after coronary artery bypass grafting with and without the use of cardiopulmonary bypass.
Topics: Adrenergic beta-Antagonists; Aged; Analysis of Variance; Atrial Fibrillation; Cardiopulmonary Bypass; Chi-Square Distribution; Cohort Studies; Coronary Artery Bypass; Electrocardiography, Ambulatory; Female; Heart Arrest, Induced; Heart Rate; Humans; Incidence; Intraoperative Care; Male; Minimally Invasive Surgical Procedures; Propanolamines; Retrospective Studies; Stroke Volume | 1999 |
Endovascular stimulation within the left pulmonary artery to induce slowing of heart rate and paroxysmal atrial fibrillation.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Atrial Fibrillation; Atropine; Autonomic Nervous System; Disease Models, Animal; Dogs; Electric Stimulation; Electrocardiography; Endothelium, Vascular; Heart Rate; Muscarinic Antagonists; Propanolamines; Propranolol; Pulmonary Artery | 2002 |
Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Cardiac Surgical Procedures; Digoxin; Dose-Response Relationship, Drug; Heart Rate; Humans; Hypotension; Infusions, Parenteral; Middle Aged; Postoperative Complications; Premedication; Propanolamines; Tachycardia | 1985 |